EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Integrated Clinical, Germline, Somatic, and In Silico Approach to Assess a Novel PMS2 Gene Variant Identified in Two Unrelated Lynch Syndrome Families

Candida Fasano, Antonia Lucia Buonadonna, Giovanna Forte, Martina Lepore Signorile, Valentina Grossi iD, Katia De Marco, Paola Sanese, Andrea Manghisi, Nicoletta Maria Tutino, Raffaele Armentano iD, Anna Maria Valentini iD, Vittoria Disciglio und 1 weitere

Cancers · 11.07.2025 · 17 (14) · 2308

DOI: 10.3390/cancers17142308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 11.07.2025. Verfasst von Candida Fasano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics, National Institute of Gastroenterology, IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, European Union - Next Generation EU - NRRP M6C2, Carlo Erba Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lynch syndrome (LS) is an autosomal dominant disease caused by germline pathogenic variants in one of the DNA mismatch repair (MMR) genes (MLH1, MSH2, MSH6, and PMS2) or the EPCAM gene. LS patients harboring genetic variants in one of the MMR genes display a heterogeneous phenotype in terms of cancer penetrance (lifetime cancer risk) and expressivity (malignancies in gastrointestinal or other specific organs).

Methods

DNA samples from the index cases of Family 1 and Family 2 were analyzed using a next-generation sequencing (NGS) multigene panel comprising 25 genes involved in major hereditary cancer predisposition syndromes. This NGS analysis revealed a variant of uncertain significance (VUS) in the PMS2 gene (NM_000535.7: c.184G>A; p.Gly62Arg) of both index cases, which was validated by Sanger sequencing. The structural and functional impact of this VUS was evaluated in silico using twelve different prediction tools and by immunohistochemical analysis of MMR proteins.

Results

Based on the personal and family history of the two families, tumor pathology, and protein in silico analysis, the novel PMS2 gene variant described in this study may be associated with hereditary LS. Considering the low penetrance of PMS2 gene variants in LS-associated tumors and the intrafamilial variability of the associated clinical phenotypes, the multidisciplinary approach proposed in this study could significantly support the evaluation of suspected LS cases carrying PMS2 variants.

Schlagwörter

Stichwörter der Autor:innen

DNA mismatch repairLynch syndromegastrointestinal cancermismatch repair endonuclease PMS2variant of uncertain significance

Autor:innen und Institutionen

  • Medical Genetics, National Institute of Gastroenterology, IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
  • Histopathology Unit, National Institute of Gastroenterology, IRCCS "Saverio de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
  • Medical Genetics, Department of Precision and Regenerative Medicine and Jonic Area (DiMePRe-J), University of Bari Aldo Moro, 70124 Bari, Italy.

ORCID-Profile: Valentina Grossi, Raffaele Armentano, Anna Maria Valentini

Förderung

  • Italian Ministry of Health
  • European Union - Next Generation EU - NRRP M6C2
  • Carlo Erba Foundation
  • European Union—Next Generation EU—NRRP M6C2

Zitieren

APA

Fasano, C., Buonadonna, A. L., Forte, G., Lepore Signorile, M., Grossi, V., De Marco, K., Sanese, P., Manghisi, A., Tutino, N. M., Armentano, R., Valentini, A. M., Disciglio, V., & Simone, C. (2025). An Integrated Clinical, Germline, Somatic, and In Silico Approach to Assess a Novel PMS2 Gene Variant Identified in Two Unrelated Lynch Syndrome Families. Cancers, 17(14), 2308. https://doi.org/10.3390/cancers17142308

Vancouver

Fasano C, Buonadonna AL, Forte G, Lepore Signorile M, Grossi V, De Marco K, et al. An Integrated Clinical, Germline, Somatic, and In Silico Approach to Assess a Novel PMS2 Gene Variant Identified in Two Unrelated Lynch Syndrome Families. Cancers. 2025;17(14):2308. doi:10.3390/cancers17142308

BibTeX
@article{Fasano2025,
  author = {Fasano, Candida and Buonadonna, Antonia Lucia and Forte, Giovanna and Lepore Signorile, Martina and Grossi, Valentina and De Marco, Katia and Sanese, Paola and Manghisi, Andrea and Tutino, Nicoletta Maria and Armentano, Raffaele and Valentini, Anna Maria and Disciglio, Vittoria and Simone, Cristiano},
  title = {An Integrated Clinical, Germline, Somatic, and In Silico Approach to Assess a Novel PMS2 Gene Variant Identified in Two Unrelated Lynch Syndrome Families},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {14},
  pages = {2308},
  doi = {10.3390/cancers17142308}
}
Kostenlos starten →